When it comes to the development and distribution of new products, pharmaceutical companies face the following market challenges, among others:
- they need to innovate
- they want a custom enzyme design
- they want to scale biocatalytic processes with a streamlined development pipeline
- they need to reduce cost and time
- they need IP security
Biocatalysts Ltd has been reacting to these requirements and started together with BRAIN Biotech Zwingenberg the initiative "BRAINBiocatalysts Life Science Solutions".
Combined expertise: The BRAINBiocatalysts Life Science Solutions is the result of a powerful combination of BRAIN Biotech’s expertise in enzyme discovery (MetXtraTM) and enzyme engineering with Biocatalysts Ltd’s commercial-scale manufacturing capabilities.
End-to-end services: Through this integration, the initiative offers end-to-end services, from enzyme discovery and industrial production strains to fermentation and production, while ensuring that customers retain full intellectual property rights.
Rapid scaling: The “Plug & Produce” microbial fermentation platform and Cardiff-based production facilities also support rapid scaling, which helps reduce both time and costs involved in bringing new biocatalytic processes to market.
Overall, BRAINBiocatalysts Life Science Solutions´unique offering is ideal for companies aiming to scale biocatalysis processes, with a streamlined development pipeline. The solutions address key market needs, like scalability, IP security, and custom enzyme design, enabling life sciences companies to innovate without limitations.
